Work

Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.1135.1135

Authors: Partow Kebriaei, Rima M. Saliba, Carrie Ma, Cindy Ippoliti, Daniel R. Couriel, Marcos de Lima, Sergio Giralt, Muzaffar H. Qazilbash, James L. Gajewski, Chul S. Ha, Richard E. Champlin, Issa F. Khouri

Institutions: The University of Texas MD Anderson Cancer Center, Georgetown University, Georgetown University Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2991687763

FWCI: 0.178

Cites:

Cited by: 3

Related to: 10